antibody-drug conjugates

Large layoffs of employees Wooden figures of people going to the exit

Biotech

Heidelberg to ax 75% of staff after milestone becomes millstone

With a regulatory blow delaying a $70 million payment, Heidelberg is reducing its workforce by 75% and narrowing its focus to extend its cash runway.

Nick Paul Taylor Sep 25, 2025 7:20am

BioNTech

BioNTech, BMS tout first global data for PD-L1xVEGF drug in SCLC

Sep 8, 2025 11:00am

An arrow incrementally going up stairs before pointing straight up Blue background

BioNTech's ADC beats Roche’s Kadcyla in breast cancer phase 3

Sep 5, 2025 7:30am

A chessboard with blocks that read MA

Sino Biopharm buys Merck’s PD-1xVEGF bispecific partner LaNova

Jul 15, 2025 10:16am

An arrow incrementally going up stairs before pointing straight up Blue background

Biokin, having landed BMS deal, posts ph. 3 bispecific ADC win

Jul 2, 2025 9:53am

Photo of a final puzzle piece about to fit into a puzzle

NextCure advances ADC pivot with $745M deal for phase 1 drug

Jun 16, 2025 9:52am